Stock Events

Stock Events

Bio Green Med Solution 

$2.84
94
+$0.34+13.54% Friday 19:38

Statistics

Day High
2.76
Day Low
2.69
52W High
7.21
52W Low
0.3
Volume
200
Avg. Volume
614
Mkt Cap
15.67M
P/E Ratio
-
Dividend Yield
21.14%
Dividend
0.6

Upcoming

Dividends

21.14%Dividend Yield
Aug 26
$0.15
May 26
$0.15
Feb 26
$0.15
Nov 25
$0.15
Aug 25
$0.15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
33.33%

Earnings

12AugExpected
Q2 2025
Q3 2025
Q1 2026
Next
-72
-48.01
-24.03
-0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,886.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
747,000Revenue
-14.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGMSP. It's not an investment recommendation.
Ares Capital
2
ARCC
T. Rowe Price Group
2
TROW
Gladstone Investment
2
GAIN
Gladstone Capital
2
GLAD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a biopharmaceutical company that competes in the development of drugs in areas such as oncology, where Cyclacel also operates.
AMGEN
AMGN
Mkt Cap196.12B
Amgen is a biotech firm focusing on human therapeutics, including treatments for cancer, which puts it in direct competition with Cyclacel's oncology focus.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb is involved in discovering, developing, and delivering innovative medicines, including cancer treatments that compete with Cyclacel's product pipeline.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a global pharmaceutical corporation with a broad portfolio, including oncology, directly competing with Cyclacel's cancer-focused therapies.
Merck
MRK
Mkt Cap305.12B
Merck is known for its high-quality research and development in pharmaceuticals, including cancer drugs, making it a competitor to Cyclacel.
Novartis
NVS
Mkt Cap293.94B
Novartis is a healthcare company that focuses on innovative medicines, with a strong emphasis on oncology, competing with Cyclacel in the cancer treatment market.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie operates in the discovery of new medicines, including for cancer, directly competing with Cyclacel's research and development in oncology.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in oncology, competing with Cyclacel.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, with a strong focus on pharmaceuticals and diagnostics in oncology, making it a competitor to Cyclacel.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson is a diverse healthcare company that has a pharmaceutical segment involved in the development of oncology treatments, competing with Cyclacel.

About

Bio Green Med Solution, Inc. (BGMSP) engages in a dual business model: the provision, sale, and setup of protective and fire safety equipment and full-scale fire prevention systems, alongside conducting pharmaceutical research and development. The firm, established in 1996, was previously known as Cyclacel Pharmaceuticals, Inc. before rebranding to Bio Green Med Solution, Inc. in September 2022. Its main offices are located in Kuala Lumpur, Malaysia.
Show more...
CEO
Employees
12
Country
United States
ISIN
US23254L2079

Listings

MU
DE
UXI4.MU
XNAS
US
BGMS
BOATS
BOATS
BGMS.BOATS
MU
DE
UXI1.MU

0 Comments

Share your thoughts

FAQ

What is Bio Green Med Solution stock price today?▼
The current price of BGMSP is $2.84 USD — it has increased by +13.54% in the past 24 hours. Watch Bio Green Med Solution stock price performance more closely on the chart.
What is Bio Green Med Solution stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Bio Green Med Solution stocks are traded under the ticker BGMSP.
Is Bio Green Med Solution stock price growing?▼
BGMSP stock has fallen by -18.9% compared to the previous week, the month change is a +146.65% rise, over the last year Bio Green Med Solution has showed a -30.09% decrease.
What is Bio Green Med Solution market cap?▼
Today Bio Green Med Solution has the market capitalization of 15.67M
When is the next Bio Green Med Solution earnings date?▼
Bio Green Med Solution is going to release the next earnings report on August 12, 2026.
What were Bio Green Med Solution earnings last quarter?▼
BGMSP earnings for the last quarter are -0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bio Green Med Solution revenue for the last year?▼
Bio Green Med Solution revenue for the last year amounts to 747,000 USD.
What is Bio Green Med Solution net income for the last year?▼
BGMSP net income for the last year is -14.09M USD.
Does Bio Green Med Solution pay dividends?▼
Yes, BGMSP dividends are paid quarterly. The last dividend per share was 0.15 USD. As of today, Dividend Yield (FWD)% is 21.14%.
How many employees does Bio Green Med Solution have?▼
As of August 02, 2026, the company has 12 employees.
In which sector is Bio Green Med Solution located?▼
Bio Green Med Solution operates in the Other sector.
When did Bio Green Med Solution complete a stock split?▼
The last stock split for Bio Green Med Solution was on May 12, 2025 with a ratio of 1:16.